搜索临床试验以:丙酸氟替卡松和沙美特罗吸入粉
总计624个结果
-
AstraZeneca完全的哮喘 | 慢性阻塞性肺疾病 (COPD)美国
-
VA Office of Research and Development终止
-
Brigham and Women's HospitalMassachusetts General Hospital; Baim Institute for Clinical Research终止
-
Taipei Veterans General Hospital, TaiwanGlaxoSmithKline未知
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
AstraZeneca完全的
-
Optinose US Inc.完全的
-
Marc Rothenberg完全的
-
Amsterdam UMC, location VUmcGlaxoSmithKline; The Netherlands Cancer Institute完全的
-
Mannkind Corporation完全的
-
GlaxoSmithKlineAdelphi Real World完全的
-
Boehringer Ingelheim终止
-
Boehringer Ingelheim终止
-
GlaxoSmithKline完全的
-
University of California, San DiegoNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Boehringer Ingelheim终止
-
Xijing Hospital未知